http://www.fpnotebook.com/
Erythema MultiformeAka: Erythema Multiforme Minor
- Pathophysiology
- Self limited mucocutaneous reaction
- Hypersensitivity Reaction to various antigens
- Types
- Erythema multiforme minor
- Now known simply as erythema multiforme
- Other forms below are distinct entities
- Erythema Multiforme Major (Stevens Johnson Syndrome)
- Previously thought to be along same spectrum as minor
- Now thought to be distinct entity
- May include toxic epidermal necrolysis
- Erythema multiforme minor
- Causes
- Idiopathic (50%)
- Herpes Simplex Virus (>50%)
- Occurs 10 days after acute eruption
- HSV may be cause even without active lesions
- Other infections
- Drug sensitivity (1-3 weeks after intake)
- Sulfonamides (e.g. Septra)
- Penicillins
- Hydantoins (e.g. Dilantin)
- Phenothiazines
- Phenobarbitals
- NSAIDs (esp. Ibuprofen)
- Bextra (FDA black box warning)
- Allopurinol
- Vaccines (Td, Hepatitis B Vaccine, Small Pox vaccine)
- Candesartan (Atacand)
- Metformin (Glucophage)
- Adalimumab (Humira)
- Bupropion (Wellbutrin)
- Ciprofloxacin
- Pregnancy
- Food Allergy
- Neoplasm
- Epidemiology
- Age: Peaks age 20-30 (20% of cases under age 18)
- Gender: Males affected more often than females
- Symptoms
- Rash develops after prodrome
- Mild prodrome for 7-10 days may be present
- Malaise
- Fever
- Headache
- Rhinorrhea
- Cough
- Signs
- Distinctive Target or Iris skin lesion
- Starts as erythematous Macule that becomes raised
- Distribution: Symmetrical involvement
- Onset on distal extremities (often dorsal hands)
- Progress proximally (often extensor surfaces)
- Oral Mucosal involvement may be present
- Develops concentrically into target lesion by day 2
- Center: Dusky erythema or Vesicle
- Middle: Pale edematous ring
- Outer: Dark band of erythema
- Progresses
- Central necrosis
- Some lesions may coalesce into annular Plaques
- Healing
- Scarring
- Postinflammatory Hyperpigmentation
- Alternative presentations
- Distinctive Target or Iris skin lesion
- Labs: None are necessary (use for differential diagnosis)
- Complete Blood Count
- Skin Biopsy (if diagnosis unclear)
- Evaluate underlying etiology
- Herpes Simplex Virus
- Tzanck Preparation of skin lesion
- Mycoplasma pneumoniae
- Complement fixation
- Cold agglutinins
- Chest XRay
- Herpes Simplex Virus
- Differential Diagnosis
- Severe illnesses with erythema multiforme type lesions
- Erythema Multiforme Major (Stevens Johnson Syndrome)
- Toxic Epidermal Necrolysis
- Chronic Urticaria
- Urticarial lesions persist <24 hours, then migrate
- Serum Sickness
- Figurate erythema
- Toxic erythema
- Viral infection
- Drug exposure
- Graft versus host disease
- Necrotizing Vasculitis
- Systemic Lupus Erythematosus
- Vesiculobullous lesions
- Bullous Pemphigoid
- Pemphigus Vulgaris
- Impetigo
- Toxic epidermal necrolysis
- Dermatitis Herpetiformis
- Behcet's Syndrome
- Reiter's Syndrome
- Mucocutaneous lesions
- Severe illnesses with erythema multiforme type lesions
- Management
- Elimination of precipitating factors
- Herpes Simplex Virus
- Mycoplasma pneumoniae
- Suspected drug or food item
- Mild Involvement: Supportive care
- Analgesics
- Oral Antihistamines
- Skin lesions
- Wet Dressings or soaks
- Topical Corticosteroids (questionable efficacy)
- Oral lesions
- Saline mouth rinses
- Moderate erythema multiforme minor
- Oral Acyclovir
- Prednisone (controversial)
- Dose: 40-80 mg PO daily for 1-2 weeks, then taper
- Recurrent erythema multiforme minor
- Systemic antivirals
- Continue until lesion-free for 4 months
- Then taper dose gradually
- First-line
- Acyclovir 400 mg PO bid
- Second-line if Acyclovir ineffective
- Valacyclovir 500-1000 mg PO daily
- Famciclovir 125 to 250 mg PO daily
- Continue until lesion-free for 4 months
- Other agents in refractory cases
- Prescribed by Dermatology
- Agents (high rate of adverse effects)
- Dapsone
- Hydroxychloroquine
- Azathoprine
- Cyclosporine
- Thalidomide
- Systemic antivirals
- Elimination of precipitating factors
- Course
- New lesions occur over 3-5 days
- Lesions persist for 1-2 weeks (non-migratory)
- Contrast with Urticaria that last <24 hours
- Resolves spontaneously in 3-5 weeks
- May recur multiple times in one year
- References
Erythema Multiforme (C0014742) | |
|---|---|
| Definition (MSH) | A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic "bull's-eye" lesions usually occurring on the dorsal aspect of the hands and forearms. |
| Definition (CSP) | skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms. |
| Concepts | Disease or Syndrome (T047) |
| ICD9 | 695.1 |
| English | Erythema Multiforme |
| Spanish | eritema multiforme, eritema polimorfo |
| Credits | Derived from the NIH UMLS (Unified Medical Language System) |
